YESCARTA (Axicabtagene Ciloleucel) Drug & Market Analysis
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Diffuse Largeb Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
Experts look back on the year in the news regarding bispecific antibodies for the treatment of B-cell lymphomas including CLL and SLL.
/PRNewswire/ -- The "EPKINLY Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report offers detailed...
After spending years trying to fight Follicular Non-Hodgkin Lymphoma, Cory Schibler, the worship pastor at Beacon Baptist Church in Bryan, Texas, is now facing a deadly mutation of the cancer as his wife, Crystal, now grapples with a grave cancer diagnosis of her own.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has passed a major milestone for its Azer-cel cell therapy treatment with the dosing of the first patient for its Phase 1b...